Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and provide a more focused and rational pathway to drug development.On October 24, 2008, the IOM’s Forum on Drug Discovery, Development, and Translation held "Assessing and Accelerating Development of Biomarkers for Drug Safety, " a one-day workshop, summarized in this volume, on the value of biomarkers in helping to determine drug safety during development.
€21.19
Koop dit e-boek en ontvang er nog 1 GRATIS!
Taal Engels ● Formaat PDF ● Pagina’s 100 ● ISBN 9780309131254 ● Editor Robert Giffin & Sally Robinson ● Uitgeverij National Academies Press ● Gepubliceerd 2009 ● Downloadbare 3 keer ● Valuta EUR ● ID 7141161 ● Kopieerbeveiliging Adobe DRM
Vereist een DRM-compatibele e-boeklezer
Meer e-boeken van dezelfde auteur (s) / Editor
33.253 E-boeken in deze categorie
